financetom
Business
financetom
/
Business
/
World's top 100 defence groups boost arms sales by 4% in 2023, think tank SIPRI says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
World's top 100 defence groups boost arms sales by 4% in 2023, think tank SIPRI says
Dec 1, 2024 3:17 PM

STOCKHOLM (Reuters) - The world's 100 biggest defence equipment makers increased their arms sales by 4.2% in 2023 to $632 billion, fuelled by wars and regional tensions, a leading think-tank said on Monday.

The Stockholm International Peace Research Institute (SIPRI) said in a report U.S. groups on the list grew sales by 2.5% in total compared to the year before to $317 billion. Market leaders Lockheed Martin ( LMT ) and RTX however saw slightly lower arms sales.

The rise followed a 3.5% dip in arms sales in 2022, which SIPRI has blamed on labour shortages, supply-chain disruptions and rising costs, which made it hard for many companies to meet increased demand driven by Russia's invasion of Ukraine.

European companies on the list - excluding Russian - had roughly unchanged combined sales in 2023 at $133 billion, but order intake surged, and some groups saw a surge in demand linked to the war in Ukraine.

Earlier this year, SIPRI reported a 7% increase in global military spending in 2023, the steepest annual increase since 2009.

"Overall, smaller producers were more efficient at responding to new demand linked to the wars in Gaza and Ukraine, growing tensions in East Asia and rearmament programmes elsewhere," SIPRI said.

The Russian groups on the list, including state-owned Rostec, accounted for the biggest combined rise - 40% to $26 billion.

"The arms revenues of the Top 100 arms producers still did not fully reflect the scale of demand, and many companies have launched recruitment drives, suggesting they are optimistic about future sales," SIPRI researcher Lorenzo Scarazzato said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Target Needs Structural Improvement to Sustain Momentum, RBC Says
Target Needs Structural Improvement to Sustain Momentum, RBC Says
Mar 11, 2026
02:22 PM EST, 02/27/2026 (MT Newswires) -- Target ( TGT ) investors are hoping for a major reinvestment news to improve its competitiveness but it may not come this quarter, RBC Capital Markets said Friday in a preview to its Financial Community Meeting, including Q4 results, on March 3. We think that announcement is less likely this qtr though, the...
J.M. Smucker Likely to Focus More on Organic Growth After Elliott's Involvement, RBC Says
J.M. Smucker Likely to Focus More on Organic Growth After Elliott's Involvement, RBC Says
Mar 11, 2026
02:19 PM EST, 02/27/2026 (MT Newswires) -- J.M. Smucker (SJM) is likely to focus more on organic growth, cost savings, and be more flexible with portfolio reshaping after Elliott Investment Management's involvement in the recent appointment of two new independent directors, RBC Capital Markets said in a Friday research note. The company's fiscal Q3 sales beat was driven by robust...
Uber's Autonomous Vehicle API Strengthens Moat Beyond Partnerships, RBC Says
Uber's Autonomous Vehicle API Strengthens Moat Beyond Partnerships, RBC Says
Mar 11, 2026
02:19 PM EST, 02/27/2026 (MT Newswires) -- Uber ( UBER ) is developing a digital and physical application programming interface that any autonomous vehicle provider can connect to, offering a wider moat than just a fragmented partner base, RBC Capital Markets said. WeRide, Uber's ( UBER ) AV partner in the Middle East, believes that competitors' cost and technology advantages...
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
Mar 11, 2026
WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transaction with a distinguished global Contract Research Organization (“CRO”). If consummated, the proposed transaction could expand Tevogen’s clinical development capabilities and could support the Company’s evolution into...
Copyright 2023-2026 - www.financetom.com All Rights Reserved